Melanie James+FollowFDA Flags Rare Heart Risk in Young MenDid you see this? The FDA just told Pfizer and Moderna to update their COVID vaccine labels with a warning about rare heart inflammation—mainly in guys 16-25. Out of a million doses, about 38 young men had issues like myocarditis or pericarditis, but most cases get better pretty fast. The FDA says they’re being extra transparent, and both companies have 30 days to respond. No public statements from Pfizer or Moderna yet, but this is definitely one to watch! #COVID19 #VaccineUpdate #HealthNews #Health53Share
Rebecca Cowan+FollowWhy Nursing Home Outbreaks Spread FastTurns out, when nursing home staff work at multiple facilities, infections like COVID-19 spread way faster—especially in crowded homes. Researchers found that keeping staff-sharing below 5% really helps stop outbreaks, but once it goes over 30%, even masks and vaccines can’t keep up. Basically, more shared staff = more risk for everyone. If you’ve got loved ones in nursing homes, this is something to watch! #NursingHomes #COVID19 #Healthcare #Health91Share
nheath+FollowFDA’s New COVID Vax Plan Has Docs SplitBig shakeup in the COVID vaccine world! The FDA’s advisors just voted to update shots for the JN.1 strain, but the real drama? The FDA’s hinting at a new plan: only high-risk folks and seniors might get recommended for future boosters, not everyone. Experts are totally split on which strain to target next, and there’s a lot of side-eye about how this will affect vaccine makers like Novavax and Sanofi. Meanwhile, political pushback is heating up. Stay tuned—this could change how we all get vaxxed! #COVID19 #FDA #Vaccines #Health01Share
Spencer Brewer+FollowFDA’s Big Move on mRNA VaccinesMajor update: The FDA is now limiting mRNA COVID shots (like Pfizer and Moderna) to folks 65+ or those with high-risk conditions. Why? They want more data for younger people and are asking for expanded warning labels about rare heart inflammation. Experts say mRNA vaccines have saved millions of lives and are still super effective. The risk of heart issues is way higher from getting COVID than from the shot. Wild how much debate is still swirling! #mRNA #COVID19 #VaccineUpdate #Health46Share
Barry Miller+FollowFDA’s COVID Vax Shake-Up: Only for High-Risk?Big news: The FDA just changed the COVID vaccine game! Now, only folks 65+ or those at high risk are getting the official vax recommendation. No more annual shots for everyone—healthy kids and adults under 65 are off the list unless new trials prove it’s worth it. The move follows super low booster rates and puts the US in line with other countries. Some are worried this could fuel more vaccine hesitancy. What do you think about this switch? #COVID19 #FDA #VaccineUpdate #HealthNews #PublicHealth #Health30Share
Spencer Brewer+FollowCOVID Vax Rules Are Getting a Shake-UpBig changes are coming for COVID-19 vaccines! The FDA wants annual boosters for healthy people under 65 to go through clinical trials first, which means most folks might not get a shot this fall unless they’re older or at higher risk. Plus, Pfizer and Moderna are being told to add warning labels about rare heart inflammation in young men. The science is still evolving, so stay tuned if you’re wondering about your next dose! #COVID19 #VaccineUpdate #FDA #HealthNews #Health141Share
Barry Miller+FollowWho Can Still Get COVID Shots?Big change alert: The FDA just announced that starting in 2025, only people 65+ or those with certain health conditions will have easy access to COVID vaccines. If you’re younger and healthy, getting your annual shot is about to get way harder. With anti-vax voices gaining power, the days of free-for-all COVID boosters are over. Docs are worried this could mean more unnecessary deaths. What do you think about the new rules? #COVID19 #FDA #Vaccines #HealthNews #PublicHealth #Health12Share
Melanie James+FollowFDA Narrows COVID Vax—Who’s Still Eligible?Big shift: The FDA just announced that only adults 65+ and people with certain health risks (think asthma, cancer, diabetes, etc.) will be able to get the new COVID-19 vaccine this fall. Healthy younger adults and kids? Not on the list unless new trials prove it’s worth it. This move is sparking debate—some say it’s about safety, others worry it’ll make vaccines harder to get and fuel more hesitancy. What do you think about this new approach? #COVID19 #VaccineUpdate #FDA #PublicHealth #VaccineNews #Health20Share
Spencer Brewer+FollowModerna’s Combo Vax Hits a RoadblockModerna just yanked its FDA application for their much-hyped combo flu/COVID shot, even after saying it worked better than current vaccines. Turns out, the FDA wants more data, so Moderna’s pushing approval back to 2026 and deprioritizing the shot for now. Their stock dropped 4.5% on the news. They’ll try again later this year when more trial results come in. Meanwhile, the FDA’s getting stricter on vaccine approvals, and Pfizer’s racing ahead with its own combo vax. Wild times in vaccine land! #Moderna #VaccineNews #Biotech #FDA #COVID19 #Health10Share
nheath+FollowFDA’s COVID Vax Move Sparks OutrageThe FDA just dropped a bomb: COVID vaccines might only be available for people over 65 or those at high risk. That means healthy adults under 65 could be out of luck until more studies are done. CT health experts are calling this 'borderline unethical'—especially since the vax has been studied like crazy. People are worried about losing their shot at protection, and honestly, the irony isn’t lost on anyone. What do you think: smart move or total misstep? #COVID19 #VaccineNews #FDA #HealthDebate #Connecticut #Health5682Share
